The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Prevalence of BRCA in Patients With Ovarian Cancer
Official Title: Prevalence of BRCA in Patients With Primary or Platinum Sensitive Recurrent Ovarian Cancer.
Study ID: NCT02222883
Brief Summary: The aim of this prospective registration and translational research study is to evaluate the praevalence of BRCA regarding germline and somatic mutations.
Detailed Description: Explorative analysis will be performed.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Charité - Universitätsmedizin Berlin, Berlin, , Germany
Universitätsklinik Carl Gustav Carus, Dresden, , Germany
Evangelisches Krankenhaus, Düsseldorf, , Germany
Kliniken Essen-Mitte, Essen, , Germany
Universitätsklinikum Essen, Essen, , Germany
Universitätsklinikum Frankfurt, Frankfurt/Main, , Germany
Universitätsklinikum Hamburg-Eppendorf, Hamburg, , Germany
Medizinische Hochschule Hannover, Hannover, , Germany
NCT Heidelberg, Heidelberg, , Germany
Universitätsklinikum Schleswig-Holstein, Kiel, , Germany
Zentrum für Gynäkologische Onkologie, Kiel, , Germany
Universitätsklinikum Schleswig-Holstein, Lübeck, , Germany
Universitätsklinikum Gießen und Marburg, Marburg, , Germany
Klinikum rechts der Isar, München, , Germany
LMU München, Klinik Großhadern, München, , Germany
Sana Klinikum Offenbach, Offenbach, , Germany
Universitäts-Frauenklinik, Tübingen, , Germany
Universitätsklinikum Ulm, Ulm, , Germany
Dr. Horst Schmidt Kliniken, Wiesbaden, , Germany
Universitätsklinikum Würzburg, Würzburg, , Germany
Name: Philipp Harter, PhD MD
Affiliation: Kliniken Essen-Mitte, Germany
Role: STUDY_CHAIR